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Proteolytical processing of the growth factor VEGFC through the concerted activity of CCBE1
and ADAMTS3 is required for lymphatic development to occur. How these factors act
together in time and space, and which cell types produce these factors is not understood.
Here we assess the function of Adamts3 and the related protease Adamts14 during zebrafish
lymphangiogenesis and show both proteins to be able to process Vegfc. Only the simulta-
neous loss of both protein functions results in lymphatic defects identical to vegfc loss-of-
function situations. Cell transplantation experiments demonstrate neuronal structures and/or
fibroblasts to constitute cellular sources not only for both proteases but also for Ccbe1 and
Vegfc. We further show that this locally restricted Vegfc maturation is needed to trigger
normal lymphatic sprouting and directional migration. Our data provide a single-cell reso-
lution model for establishing secretion and processing hubs for Vegfc during developmental
lymphangiogenesis.
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The lymphatic vasculature fulfills pivotal functions formaintaining tissue fluid homeostasis, for providingimmune surveillance by transporting immune cells and
soluble antigens, and for uptake and transport of dietary lipids
from the small intestine. Lymphatic vessels form through a
dynamic process called lymphangiogenesis which comprises
sprouting and migration of lymphatic precursor cells from the
venous endothelium leading to the formation of the first lym-
phatic structures that are connected to the venous system1.
Zebrafish lymphatic development is tightly linked to the for-
mation of intersegmental veins in the trunk. At about 32 hours
post fertilization (hpf), sprouts emerge from the posterior cardi-
nal vein (PCV). Almost half of these venous or secondary sprouts
establish connections with arterial intersegmental vessels (aISVs)
resulting in their remodeling into venous ISVs (vISVs). The other
half of the sprouts migrate dorsally to the horizontal myoseptum
(HM), where they transiently form a pool of lymphatic precursor
cells named parachordal lymphangioblasts (PLs) at 48 hpf.
Slightly later, at around 72 hpf, these PLs leave the HM region
and migrate along aISVs in dorsal and ventral directions to form
the trunk lymphatic vasculature, with the main lymphatic vessel
(thoracic duct; TD) situated between the dorsal aorta (DA) and
the PCV2,3.
The key chemo-attractant for lymphatic endothelial cells
(LECs) is vascular endothelial growth factor C (VEGFC). VEGFC
is produced as a pre-pro-protein which, upon secretion, gets
proteolytically cleaved at its C terminus by protein convertases
such as Furin4. To obtain full biological activity, a second, N-
terminal processing step is required before then the fully mature
VEGFC binds with high affinity to vascular endothelial growth
factor receptor 3 (VEGFR3 or Flt4), triggering downstream sig-
naling events5. The extracellular VEGFC-processing machinery
comprises collagen and calcium-binding EGF domain 1 (CCBE1),
an essential component for processing of pro-VEGFC6–10. The
actual processing step is mediated by A disintegrin and metal-
loprotease with thrombospondin motifs-3 (ADAMTS3)8. Loss-
of-function of the gene leads to impaired lymphatic development
in mice11,12 and lymphedema formation in human patients13.
The genetic conservation of VEGFC signaling components is
remarkable, with mutations in the respective zebrafish and
murine genes leading to a complete absence of lymphatic
structures14,15. Furthermore, mutations in the human ortholo-
gues of these genes have been identified as causative for several
congenital lymphedema syndromes16. The cellular sources of
these proteins, however, remain enigmatic, and given the
importance of these secreted factors for lymphangiogenesis, it is
surprising that neither the tissue distribution of VEGFC, CCBE1,
and ADAMTS3, nor their exact interaction in time and space has
been resolved. Here we address the question how Vegfc, Ccbe1,
Adamts3, and Adamts14 coordinate spatially and temporally to
regulate lymphangiogenesis in the zebrafish embryo. We find that
adamts3 and adamts14 are both sufficient to activate Vegfc
in vivo, and only double mutants phenocopy the vegfc mutant
phenotype. Expression analysis of these proteases identifies that
both enzymes are not only provided by neuronal tissues but
furthermore by cells close to the migration path taken by the
secondary sprouts, including expression in the HM region. Using
cell transplantation approaches, we find that both neuronal as
well as non-neuronal expression domains of either protease are
sufficient to locally rescue sprouting defects in double mutants. In
depth analysis of non-neuronal expression domains via single cell
sequencing and analysis of several novel transgenic reporter lines
revealed that a subpopulation of pdgfra-positive fibroblasts locally
secretes both proteases at the HM. Importantly, the identical
population of fibroblasts also provides Ccbe1 and Vegfc at the
HM, allowing Vegfc release and activation in the region. We
furthermore show that the activation of Vegfc in this area is key
for the migration of PL cells to the HM, suggesting a model in
which the overlapping expression of adamts3, adamts14, vegfc,
and ccbe1 in the fibroblast population at the HM leads to local
processing of Vegfc which in turn guides lymphatic precursor
cells to this position within the embryo.
Results
Procollagen N-proteinase function during lymphangiogenesis.
In order to study Adamts3 function in zebrafish, we generated
two adamts3 knockout alleles harboring out-of-frame deletions in
exon 3 (encoding the prodomain) or exon 5 (encoding the cat-
alytic metalloproteinase domain) (Fig. 1a). For both alleles,
crosses of heterozygous carriers did not yield embryos with
lymphatic defects. At 48 hpf adamts3 mutants showed normal PL
formation (Fig. 1b–d), and a wild-type TD at 5 dpf (Fig. 1f–h).
Given the strong evolutionary conservation of key pathway
members of the Vegfc/Flt4 signaling axis, we wondered whether
another related protease might be involved in Vegfc processing.
Besides the two other members of the so-called procollagen N-
proteinase family, adamts2 and adamts1417, an additional related
gene exists in zebrafish, termed adamts2_like. We introduced
frame-shift causing mutations in exons encoding the conserved
catalytic metalloproteinase domains for all three genes (Fig. 1a,
Supplementary Fig. 1a). Single mutants for any of these three
genes did not interfere with lymphatic development (Fig. 1e, i,
Supplementary Fig. 1b, c). However, analysis of all possible
double mutant situations revealed lymphatic defects upon
simultaneous loss of adamts3 and adamts14, but in no other
allelic combination (Fig. 1j). adamts3;adamts14 double mutant
embryos completely lacked PLs and, reminiscent of vegfc and
ccbe1 mutants, also lacked vISVs at 48 hpf, suggesting that venous
sprouting is likewise completely blocked (Fig. 1k, l; Supplemen-
tary Movies 1 and 2). Double mutants also lacked all lymphatic
structures in the trunk at 5 dpf (Fig. 1m). In embryos harboring at
least one functional copy of either adamts3 or adamts14, lym-
phatic development was unaffected (Supplementary Fig. 1d, e),
suggesting that both proteins have redundant functions during
secondary sprouting. Furthermore, we found that both facial
lymphatic vessels18,19 and also the recently discovered lymphatic
cell population within the meningeal layer of the zebrafish
brain20–22 are completely absent in double mutant embryos
(Fig. 1n, o). In addition, double mutants displayed a variable
strong curvature of the trunk, which we occasionally also
observed in adamts3+/−;adamts14−/− embryos with wild-type
lymphatics (Fig. 1p, q). We conclude that the activity of Adamts3
and Adamts14 is an essential component of Flt4-driven lymphatic
development in zebrafish, with both genes acting redundantly.
Adamts3 and Adamts14 are both able to process Pro-Vegfc.
The combined loss of Adamts3 and Adamts14 resembles defects
seen when blocking the Vegfc signaling pathway, suggesting that
both proteases mediate the processing of Pro-Vegfc during zeb-
rafish lymphangiogenesis. In order to substantiate this notion, we
took advantage of an in vivo Vegfc activity assay23. Here, the
unprocessed, full-length form of zebrafish Vegfc is expressed
ectopically from the floorplate, resulting in a strong venous
hyper-branching phenotype in wild-type embryos (Fig. 2a, b). In
mutants with reduced Vegfc processing, this dominant phenotype
is suppressed10. Overexpression of Vegfc from the floorplate did
not result in hyper-branching in adamts3;adamts14 double
mutants (Fig. 2c) which is in line with the complete loss of
Adamts3 and Adamts14 activity resulting in a blockage of Vegfc
processing. However, one functional copy of adamts3 or
adamts14 seems sufficient to trigger the hyper-branching
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phenotype (Fig. 2d, e), demonstrating that both zebrafish proteins
are able to process Vegfc.
Since previous reports suggested that human ADAMTS14 is
unable to cleave VEGFC8, we wondered whether the zebrafish
enzyme is able to process human VEGFC in vivo. Transient
floorplate expression of full-length human VEGFC resulted in
venous hyper-branching in the proximity (Fig. 2f), as shown
previously23. Analogous to what we have seen for zebrafish Vegfc,
both adamts3 and adamts14 single mutants still displayed
dominant hyper-branching phenotypes, while the only allelic
combination in which the effects were suppressed was adamts3;
adamts14 double mutant (Fig. 2g–i). Hence, zebrafish Adamts14
can cleave human VEGFC in vivo, which prompted us to re-assess
the ability of human ADAMTS14 to process VEGFC in vitro.
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To this end, we used conditioned medium of HEK293 cells,
expressing human pro-VEGFC in the presence of the serine
protease inhibitor AEBSF (to prevent cutting by plasmin) and the
furin inhibitor Decanoyl-RVKR-CMK (to retain significant
amounts of unprocessed full-length VEGFC). Under these
conditions, a full-length VEGFC band at 58 kDa and the C-
terminally processed 31 kDa form can be detected, indicating that
Furin inhibition is only partial (Fig. 2j). Addition of enriched
recombinant ADAMTS3, however, resulted in a decrease of these
58 kDa and 31 kDa polypeptides and the emergence of a 45 kDa
as well as of the fully mature 21 kDa form of VEGFC (Fig. 2j),
consistent with the previously reported VEGFC cleavage activity
of ADAMTS38,11. Of note, N-terminal processing was also
evident after incubation of the conditioned medium with
enriched ADAMTS14 protein, indicating that also human
ADAMTS14 has the capacity to cleave VEGFC. ADAMTS3-
and ADAMTS14-dependent VEGFC processing was completely
abolished by EDTA, an inhibitor of metalloproteinase activity.
Taken together, this in vitro assay demonstrates that N-terminal
processing of human VEGFC can not only be mediated by
ADAMTS3 but also by ADAMTS14, a finding that is in line with
human VEGFC overexpression phenotypes depending on zebra-
fish Adamts14 activity in vivo (Fig. 2i).
adamts3 is expressed along the migration route of PL cells. To
examine the expression pattern of adamts3, we performed in situ
hybridization (ISH) on embryos at 36 and 48 hpf (Fig. 3a–c).
Consistent with previously published data24, strong expression in
the spinal cord was observed (Fig. 3a). We furthermore noticed
weak expression in cells located around the main axial blood
vessels, the DA and PCV, at both stages (Fig. 3b, c). To analyze
adamts3 expression in more detail, we generated an adamts3:
Gal4FF reporter line. At 48 hpf, transgenic embryos showed
prominent expression in the spinal cord and axonal extensions
(Fig. 3d) of motoneurons co-expressing the motoneuronal marker
mnx1 (Fig. 3e-g). In zebrafish embryos, three different types of
motoneurons exist per segment, namely the rostral primary
motoneuron (RoP), the middle primary motoneuron (MiP), and
the caudal primary motoneuron (CaP), all projecting into dif-
ferent parts of the musculature25 (Fig. 3h). By using kdrl:mCherry
to highlight endothelial cells and adamts3:Gal4FF;UAS:GFP, we
observed that axonal extensions of adamts3-positive RoP moto-
neurons were positioned in close proximity to PL cells at the HM
at 48 hpf, while adamts3-positive CaP axons extended further
ventrally passing by the DA and PCV (Fig. 3i, m). Weaker
adamts3 expression domains were found within cells located at
the segment boundaries along the migration route of lymphatic
precursor cells (Fig. 3i, j). We furthermore noticed adamts3-
expressing cells lining the HM and ending up juxtaposed to PL
cells (Fig. 3k, m, Supplementary Movie 3), as well as single
adamts3-positive non-endothelial cells around the DA and PCV
(Fig. 3l). Several of these expression domains (Fig. 3n), including
the expression within RoP axons, correlate spatially with the
migration routes of secondary sprouts from the PCV giving rise
to both, vISVs and lymphatic precursors at the HM.
adamts14 is expressed in the floorplate and at the HM. We next
analyzed adamts14 expression patterns. At 26 hpf, shortly before
the onset of venous sprouting, expression was most prominent in
the floorplate as detected by ISH (Fig. 4a, b). In addition, we
identified staining around the DA and PCV, along ventral seg-
ment boundaries (Fig. 4b), and at the HM level (Fig. 4c, d).
During secondary sprouting stages at 36 hpf, adamts14 expression
remained strong in the floorplate and was detectable around the
DA and PCV (Fig. 4e, f) and in cells located at the HM (Fig. 4g,
h). At 48 hpf, when PLs have already reached the HM region,
expression was still evident in the floorplate (Fig. 4i, j), in cells
around the DA and PCV (Fig. 4j) and to a lesser extent at the HM
(Fig. 4k, l). Since there are no adamts14 BACs available covering
the relevant genomic region, we decided to additionally perform
RNAscope26, and were indeed able to detect adamts14 RNA
granules at the level of the HM (Fig. 4m, n). In sum, adamts14 is
expressed by the floorplate, by tissue at the level of the main axial
vessels and furthermore by cells at the HM during venous
sprouting stages (Fig. 4o).
Analysis of lymphatic-relevant adamts3 expression domains.
To identify adamts3 expression domains essential for venous
sprouting, we aimed at generating tissue-specific adamts3 knock-
outs using CRISPR/Cas9-based approaches27–29. However, due to
mosaic expression using this Gal4/UAS-driven technique, we
were unable to efficiently target adamts3 and did not observe a
phenotype even when driving expression of the constructs ubi-
quitously in adamts3+/−;adamts14−/− embryos. Since Adamts3
is a secreted enzyme, a mosaic deletion is presumably insufficient,
as even a few adamts3 wild-type cells per segment will likely
provide relevant amounts of the protease.
We therefore continued by assessing which adamts3 expression
domains are sufficient to trigger venous sprouting and PL
migration, and carried out a series of heterochronic cell
transplantation experiments, transferring cells from donors
mutant for adamts14 (but wild-type for adamts3) into double
mutant embryos. We used adamts3:Gal4FF;UAS:GFP transgenic
Fig. 1 Lymphangiogenesis is completely abolished in adamts3; adamts14 double mutant embryos. a Schematic of Adamts3 and Adamts14 protein
structures depicting the predicted effects of the indicated deletion alleles. Shown are the aa positions of the deletion-induced frame shifts (red letters) as
well as the position of the resulting premature stop codons. SP signal peptide, MPD metallopeptidase domain, ACR ADAM cysteine-rich domain 2, TSP1
thrombospondin type-1. b Schematic representation of the wild-type trunk vasculature at 48 hpf. c–e, g–i, and l–q flt4:mCitrine; flt1:tdTomato double
transgenic embryos highlighting arterial ECs in red and venous and lymphatic structures in green. In wild-type (c), adamts3 (d) or adamts14 single mutants
(e), PL cells align at the HM at 48 hpf (arrows). f Schematic representation of the trunk vasculature at 5 dpf with the thoracic duct (TD) being located
between DA and PCV. Compared with wild type (g), neither homozygous adamts3 (h) nor adamts14mutants (i) exhibit lymphatic defects at 5 dpf (arrows).
j Table summarizing the analysis of lymphatic phenotypes in all double mutant combinations for adamts2, adamts2_like, adamts3, and adamts14. k At 48 hpf,
the number of PLs was quantified in n= 53 siblings and n= 30 adamts3; adamts14 double mutants and the number of vISVs was quantified in n=
37 siblings and n= 11 double mutants. Box-and-whisker plots show median and quartiles with whiskers indicating minimum/maximum values (source data
are provided as a Source Data file). l adamts3; adamts14 double mutants lack PLs (white asterisks) and do not form vISVs (blue asterisks) at 48 hpf. m At
5 dpf, the TD is completely absent in double mutants (white asterisks). Facial lymphatics (blue arrows) and meningeal lymphatics (yellow arrow) are
formed in siblings at 5 dpf (n) but are absent in adamts3; adamts14 double mutants (o). In contrast to their siblings (p), double mutants (q) display a
variably strong curvature of the trunk. Scale bars in c–e, g–i, l–o: 50 µm; p, q: 100 µm. aa amino acid, bp base pair, dpf days post fertilization, ECs endothelial
cells, DA dorsal aorta, DLAV dorsal longitudinal anastomotic vessel, hpf hours post fertilization, HM horizontal myoseptum, a/vISV arterial/venous
intersegmental vessel, PCV posterior cardinal vein, PL parachordal lymphangioblast, VTA vertebral artery.
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Fig. 2 Adamts3 and Adamts14 are both able to process pro-Vegfc. a Schematic depiction of the in vivo Vegfc-processing assay. In wild-type embryos,
floorplate expression of full-length Vegfc results in venous hyper-branching at 48 hpf. b–e flt4:mCitrine; flt1:tdTomato transgenic embryos with arterial
structures in red and venous and lymphatic structures in green. b, c While forced expression of full-length zebrafish Vegfc from the floorplate leads to
hyper-branching in wild-type embryos (b, arrows), this dominant phenotype is not visible in adamts3; adamts14 double mutants (c, asterisks). Allelic
combinations with one remaining wild-type copy of either adamts3 (d) or adamts14 (e) develop the Vegfc-induced hyper-branching phenotype. Blue lines
indicate the floorplate position (n= 225 analyzed embryos). f–i Mosaic expression of full-length human VEGFC in floorplate cells (marked by tagRFP
expression) results in local venous hyper-branching in wild-type embryos (f), but not in adamts3;adamts14 double mutants (g). One functional copy of
either gene (h, i) is sufficient to restore the dominant phenotypes (n= 157 injected tagRFP+ embryos). Scale bars: 50 µm. DA dorsal aorta, DLAV dorsal
longitudinal anastomotic vessel, hpf hours post fertilization, HM horizontal myoseptum, a/vISV arterial/venous intersegmental vessel, PCV posterior
cardinal vein, PL parachordal lymphangioblast. j N-terminal processing of human VEGFC by ADAMTS3 and ADAMTS14 proteases. Conditioned medium
from HEK293 cells expressing full-length VEGFC was incubated with ADAMTS3, ADAMTS14, or control buffer, in the presence or absence of EDTA.
VEGFC forms were analyzed by Western blotting. In absence of active ADAMTS proteins (lanes 2, 4, and 5), VEGFC can be detected as a 58 kDa (full-
length VEGFC without SP) and a 31 kDa form (C-terminally processed VEGFC without SP). In the presence of active ADAMTS14 (lane 1), the 58 kDa form
is converted into a 45 kDa polypeptide while the 31 kDa form is processed into the fully mature 21 kDa VEGFC, which is in line with N-terminal processing
of VEGFC proteins. A similar shift in VEGFC forms is detectable in the presence of active ADAMTS3 (lane 3) [source data are provided as a Source Data
file]. Schematic depicting different VEGFC forms and their molecular weights. SP signal peptide, NT N-terminal propeptide, VHD VEGF homology domain,
CT C-terminal propeptide.
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donors injected with Dextran-Alexa647 in order to trace all
transplanted cells, while specifically highlighting those with
adamts3 expression (Fig. 5a). Since adamts3;adamts14 double
mutants do not exhibit any vISVs or PL cells (Fig. 1k), formation
of those structures in double mutant host embryos would indicate
rescuing capacity for the transplanted cells.
Previous work postulated a role for motoneurons in lymphatic
guidance, since ablation of motoneurons was shown to cause
defects in PL formation30. The molecules mediating this
interaction, however, remained unknown. As adamts3;adamts14
double mutants neither displayed motoneuron loss nor any axonal
pathfinding defects (Supplementary Fig. 2), we wondered whether
adamts3 expression in motoneurons could affect sprouting and
migration of venous ECs. In cell transplantations with adamts3+
RoP and CaP motoneurons, both PLs and vISVs were formed in
the proximity of these neurons at 48 hpf (Fig. 5b, c, Supplemen-
tary Movie 4). This demonstrates that motoneuronal expression of
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allows local rescue of the venous sprouting defects in double
mutant embryos, establishing a direct molecular connection
between embryonic motoneurons and the control of venous
sprouting.
Independently, we also observed PL and intersegmental vein
development in embryos in which transplants only contained non-
neuronal adamts3+ cells populating the HM region, the segment
boundary, and the DA and PCV region (Fig. 5d, e). In these
instances, PLs were always juxtaposed to adamts3+ cells at the
HM, suggesting a local relationship between the source of Adamts3
and the final PL position. When transplanted adamts3+ cells
populated the segment boundary together with adamts3+ cells
around the DA and PCV, both lymphatic precursor cells and vISVs
were detectable in the immediate vicinity at 48 hpf (Fig. 5f, g,
Supplementary Movie 5). Finally, in cases where transplants gave
rise to adamts3-expressing cells both around the PCV and at the
HM, a full local rescue with vISVs and PLs juxtaposed to the
adamts3-positive cells at the HM was evident (Fig. 5h, i). Together,
these findings demonstrate additional non-neuronal adamts3
sources to be sufficient to locally induce sprouting from the
PCV, leading to the formation of both veins and PL cells (Fig. 5j).
Identification of essential expression domains of adamts14.
Analogous to what we did for adamts3, we performed trans-
plantation experiments where adamts3 mutant cells containing at
least one adamts14 wild-type copy were transplanted into
adamts3;adamts14 double mutant recipients (Fig. 6a). In the
absence of a transgenic reporter construct, we relied on labeling
donor cells by Dextran-Alexa647 injection. Transplants con-
tributing to bigger patches of floorplate cells, which is the most
prominent adamts14 expression domain in the embryo, resulted
in vISV formation and smaller endothelial sprouts at the HM in
double mutants, reminiscent of normal PL cells (Fig. 6b–d,
Supplementary Movie 6). Hence, Adamts14 provided from the
floorplate can trigger sprouting of venous ECs from the PCV,
identifying Adamts14 as a floorplate-derived factor influencing
lymphangiogenesis.
Alternatively, when transplanted cells contributed to the
myotome, we found two different scenarios: rescue of vISVs
and PL formation was only evident in embryos in which
transplants not only gave rise to muscle cells, but also to
additional groups of Alexa647-positive cells located at the HM,
next to a segment boundary and around the DA and PCV
(Fig. 6e–h, Supplementary Movie 7), all regions in which we had
detected adamts14 expression before. Cases, however, in which
transplants contributed exclusively to muscle, never showed
rescue (Fig. 6i–k), suggesting that these additional non-floorplate
cells of unknown identity represent the essential Adamts14 source
to provide rescuing activity. Again we noticed that PL cells
appeared juxtaposed to transplanted cells at the HM region,
similar to what we had observed for adamts3 transplants
(Fig. 6l–n, Supplementary Movie 8). In conclusion, besides the
adamts14 floorplate expression domain, also cells positioned
around the migration route of venous sprouts close to the axial
vessels, along segment boundaries, and at the HM are sufficient to
provide Adamts14 to an extent that restores secondary sprout
migration in a locally restricted fashion in double mutant
embryos (Fig. 6o).
adamts3+ cells co-express vegfc, ccbe1, and adamts14. The cell
transplantation data suggested an involvement of thus far
uncharacterized cell populations located at the HM, the segment
boundaries and around the DA and PCV in terms of Vegfc-
processing and enabling venous sprouting. To better understand
which cell types express adamts3, we performed fluorescence-
activated cell sorting (FACS) followed by RNA sequencing, using
adamts3:Gal4FF;UAS:GFP transgenic embryos at 48 hpf. In order
to enrich for non-neuronal adamts3+ cells we also sorted for the
pan-neuronal transgene Tg(NBT:dsRed) reasoning that neuronal
adamts3-expressing cells would be double positive while non-
neuronal adamts3-expressing cell types should only exhibit a GFP
signal (Supplementary Fig. 3a). Double negative cells served as a
control population (Fig. 7a).
As expected from our ISH results, GFP+ dsRed+ neurons
showed significantly higher adamts3 levels than the non-
fluorescent control population (Fig. 7b). The same cell population
also showed twofold enrichment of adamts14 expression
compared with the negative population, possibly reflecting
adamts14 floorplate expression or the existence of a potential
neuronal subpopulation expressing adamts14. When comparing
the GFP+dsRed− population (non-neuronal adamts3-expressing
cells) to the control, we detected the predicted enrichment for
adamts3 transcripts. This enrichment appeared lower compared
with the neuronal population, which is consistent with the overall
higher expression levels of adamts3 in motoneurons (Fig. 3).
adamts3+ cells also showed increased adamts14 mRNA levels,
suggesting that both genes are co-transcribed in non-neuronal
cells, a notion in line with the transplantation results. We
reasoned that other genes involved in the Vegfc-processing
machinery might also be co-expressed in these cells and analyzed
ccbe1 expression levels. Previously we have reported that ccbe1 is
expressed in a dynamic fashion along the migration route of
lymphatic precursor cells including expression along the segment
boundaries and at the HM by mesodermal cells6. While co-
expression of adamts3 and ccbe1 in GFP+dsRed+ neurons is
not evident, we found a 3.3-fold ccbe1 enrichment within the
Fig. 3 adamts3 is expressed by motoneurons and additional cell types during venous sprouting stages. a–c Whole mount in situ hybridization against
adamts3 at 36 and 48 hpf indicates strong expression in the spinal cord (arrow) and weaker expression of adamts3 transcripts around the axial blood
vessels in the trunk (arrowheads). d The adamts3:Gal4FF; UAS:GFP transgenic reporter line shows very prominent expression (in green) in neuronal cells
(arrow). e–g The adamts3:Gal4FF; UAS:RFP transgene shows expression in trunk neurons and axons that are also labeled by the motoneuronal marker mnx1:
GFP at 48 hpf. h Diagram of the three different types of motoneurons per segment, differing in their axonal projections which either extend along the HM
region (rostral primary motoneuron, RoP, shown in magenta), toward the dorsal side of the trunk (middle primary motoneuron, MiP, highlighted in orange)
or that extend further ventrally, passing by the main axial blood vessels (caudal primary motoneuron, CaP shown in blue). i–l adamts3:Gal4FF; UAS:GFP; kdrl:
mCherry transgenic embryos, highlighting adamts3 expression domains in green and ECs in red at 48 hpf. i Higher magnification of the trunk region,
showing adamts3 reporter expression not only in neurons (arrowhead) but also in non-neuronal cells located at the segment boundaries (arrows). White
lines indicate the position of the segment boundaries. j Higher magnification of the ventral trunk region, indicating the position of adamts3-expressing cells
along the segment boundaries (arrows). k Partial z-projection of the HM region indicating expression of the adamts3 reporter (in green) in the RoP axon
(arrowhead) and in cells along the HM (arrow), which are in close proximity to the PL cells (in red). l In partial z-projections of the trunk, individual
adamts3-positive cells around the DA and the PCV are apparent (arrows). m Virtual cross section of the trunk region shown in i. n Schematic cross view
illustrating the different adamts3 expression domains (green) in the trunk.; Scale bar in a, d: 100 µm; b, c, e–g, i–m: 50 µm. DA dorsal aorta, ECs endothelial
cells, hpf hours post fertilization, HM horizontal myoseptum, M muscle, N notochord, PCV posterior cardinal vein, PL parachordal lymphangioblast.
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non-neuronal adamts3-expressing cell population, suggesting at
least a partial overlap between adamts3 and ccbe1 expression.
Although vegfc expression, based on ISH, has thus far only been
reported in arterial and hypochord cells during secondary
sprouting stages31,32, we checked vegfc expression levels in
adamts3+ cell populations and found that non-neuronal
adamts3+ cells also showed an 3.6-fold vegfc mRNA enrichment.
These unexpected results suggest that several lymphangiogenic
factors, including Vegfc itself, are co-expressed by non-neuronal
adamts3-expressing cells that are localized close to the migration
route of venous and lymphatic secondary sprouts.
Given the importance of any additional expression domains of
vegfc and ccbe1 for understanding the temporal-spatial control of
localized Vegfc processing, we generated a series of transgenic
reporter lines, that would possibly enable us to address co-
expression of adamts3 with other important lymphangiogenic
players at single cell resolution. For vegfc, expression in the
hypochord, the DA and intersegmental arteries has been reported
previously31,32, all expression domains that are relatively distant
to the destination of migrating lymphatic precursors. We
generated Tg(vegfc:Gal4FF) and Tg(vegfc:mCitrine) BAC reporter
lines, confirming vegfc expression in both hypochord and arterial
cells. In addition, we found weak expression in individual spinal
cord neurons, but also observed a strong signal in the HM region
(Fig. 7c). Careful examination revealed the presence of individual
mesenchymal cells lining the HM, in intimate contact to PL cells
at 48 hpf (Fig. 7c–f). To verify this additional vegfc expression



































Fig. 4 adamts14 expression can be detected in the floorplate and at the horizontal myoseptum. a–lWhole mount in situ hybridization for adamts14. a–d At
26 hpf, adamts14 transcripts are detectable in the floorplate (black arrow), in cells along the ventral aspect of the segment boundaries (white arrow) and in cells
at the HM (black arrowhead). d Zoom-in of the squared region in c. e–h At 36 hpf, adamts14 expression is visible in the floorplate (black arrow), in cells located
at the level of the axial blood vessels (white arrow) and in cells at the HM (black arrowhead). h Zoom-in of the indicated region in g. i–l Expression of adamts14
is still apparent in the floorplate (black arrow) at 48 hpf as well as in cells at the HM (black arrowhead). l Enlargement of the boxed region in k. m, n adamts14
RNA granules can be detected in cells located in the HM region by RNAscope at 48 hpf. n Overlay of the bright field and confocal image for the indicated
region inm, showing adamts14 RNA granules in green. o Schematic cross view of the trunk illustrating the adamts14 expression domains (yellow). Scale bars in
a, e, i: 100 µm; b, c, f, g, j, k,m: 50 µm. DA dorsal aorta, hpf hours post fertilization, HM horizontal myoseptum, M muscle, N notochord, PCV posterior cardinal
vein, PL parachordal lymphangioblast.
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compared with our standard protocol and uncovered a signal at
the HM, confirming the expression of vegfc in this region of the
embryo (Supplementary Fig. 4). We furthermore generated a Tg
(ccbe1:mCit) BAC reporter and, in addition to the prominent
expression in the pronephric duct and the epiphysis (Fig. 7g), we
also observed expression in cells at the segment boundaries and
the HM (Fig. 7h, i), consistent with previous ISH data6. Again, in
segments where PL cells were present, they were always in direct
contact with ccbe1+ cells at the HM (Fig. 7i, j).
We employed these reporter tools to investigate whether
adamts3, vegfc, and ccbe1 are co-expressed within the mesenchymal
cells at the HM. Substantiating the RNAseq results, we found some
vegfc-expressing cells at the HM to also express adamts3 (Fig. 7k, l).
Similarly, we observed co-expression of adamts3 and ccbe1
transgenes at the midline (Fig. 7m, n) and consequently also
overlapping expression of vegfc and ccbe1 (Fig. 7o, p). Compared
with UAS:GFP, the UAS:RFP reporter line would mark the
respective cells at the HM only in a mosaic fashion for all employed
Gal4FF reporter lines, likely due to partial silencing of the UAS
elements33,34. Hence it remains open whether the overlap between
the mesenchymal cells expressing adamts3, ccbe1, or vegfc would be
partial or possibly complete.
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The adamts3+, ccbe1+, and vegfc+ HM cells co-express pdgfra.
The identification of mesenchymal cells expressing all known
factors involved in the critical N-terminal processing of Vegfc
prompted us to characterize the nature of these cells further. Based
on their location and morphology, we excluded them to represent
skeletal muscle or neuronal cells, and reasoned that these cells
might reflect a fibroblast population. As pdgfra is considered a
reliable marker for fibroblasts35, we generated a Tg(pdgfra:mCit)
transgenic reporter line. At 48 hpf, pdgfra-expressing cells were
visible throughout the embryo (Fig. 8a, b), particularly populating
the HM (Fig. 8c–e) and the segment boundary regions (Fig. 8f).
Furthermore, additional pdgfra+ cells were found juxtaposed to
axial and intersegmental blood vessels (Fig. 8f, g). At the HM,
pdgfra-expressing cells were positioned close to PLs, comparable
with the situation for adamts3, vegfc and ccbe1-expressing cells
(Fig. 8c–e). Indeed, all adamts3-positive cells in the region were
also positive for the pdgfra reporter, indicating that a sub-
population of pdgfra-positive cells provides Adamts3 at the HM
(Fig. 8h–m). Analogous co-expression in mesenchymal cells at the
HM was found for vegfc and pdgfra reporters (Fig. 8n–s) and ccbe1
and pdgfra transgenes(Fig. 8t–y). We noticed that signal intensities
for all analyzed transgenes varied between individual cells at the
HM, suggesting the actual expression levels of the respective genes
to be heterogeneous among the mesenchymal cell population.
Taken together, these results suggest that the adamts3, ccbe1, and
vegfc-expressing mesenchymal cells at the HM reflect a sub-
population of pdgfra-positive fibroblasts.
Given the lack of an adamts14 reporter line, we turned to
RNAscope26, a technique that allows the simultaneous visualiza-
tion of RNA granules for up to three different genes. We
confirmed the expression of adamts14, pdgfra, ccbe1, and vegfc at
the HM (Supplementary Figs. 5–7). However, dense packing and
irregular shapes of cells in this part of the embryo hampered a
reliable assessment of whether individual cytoplasmic RNA
granules resided within the same or in neighboring cells. We
therefore restricted co-expression analysis to individual confocal
sections focusing on RNA granules that overlapped with
individual DAPI signals and that therefore should reside within
the same nucleus and hence the same cell. Following this strategy,
we confirmed co-expression of vegfc and pdgfra, of ccbe1 and
pdgfra as well as co-expression of vegfc and ccbe1 (Supplementary
Figs. 5 and 6a). We also found cells that co-expressed adamts14
with vegfc, ccbe1, or pdgfra mRNA (Supplementary Figs. 6b and
7), suggesting that adamts14 is transcribed in at least part of the
pdgfra-positive HM fibroblasts. Due to the aforementioned
technical difficulties, however, we were unable to quantitatively
assess the extent of co-expression between the individual Vegfc-
processing components using this technique.
Mesenchymal cells at the HM represent a fibroblast subtype. To
characterize the pdgfra+mesenchymal cell population further
and to firmly establish their identity, we carried out single-cell
RNA sequencing (scRNAseq). While adamts3 and ccbe1 are not
only expressed in HM cells but also in cells at the segment
boundaries and around the DA and PCV, we took advantage of
the rather confined and strong expression of the vegfc:Gal4FF;
UAS:GFP transgene in those cells at the HM, along with arterial
ECs and hypochord cells at 48 hpf (Fig. 7c–e). We furthermore
took into consideration that the expression of adamts3, adamts14,
ccbe1, and vegfc might occur in a salt-and-pepper-like pattern,
resulting in some cells expressing one particular combination of
those genes while others might express a different combination.
Hence, we used the pdgfra transgene to additionally sort for a
broader fibroblast population. Employing either vegfc:Gal4FF;
UAS:GFP;kdrl:mCherry double transgenic embryos or embryos
harboring the pdgfra:mCit reporter, we established a partial dis-
sociation protocol in which the trunks were only superficially
dissociated. We thus enriched for peripheral cells (such as cells
positioned at the HM) while reducing the respective representa-
tion of more medial cells (e.g., DA or hypochord cells) in the cell
suspension (Fig. 9a) and FAC-sorted in total three different cell
populations that were subsequently subjected to single cell
sequencing: (1) vegfc:Gal4FF;UAS:GFP+ ; kdrl:mCherry- cells, (2)
kdrl:mCherry+; vegfc:Gal4FF;UAS:GFP- cells, and (3) pdgfra:
mCit+ cells (Supplementary Fig. 3b, c).
A total of 1109 single cell transcriptomes from all three cell
populations was subsequently divided into 24 Pagoda2 clusters
(Fig. 9b, Supplementary Fig. 8a, b). Guided by canonical cell-class
marker expressions, we identified an endothelial cell cluster
(cluster 20) that consisted exclusively of kdrl:mCherry+ cells and
that expressed markers such as pecam1, dll4, cdh5, fli1a, and fli1b
(Supplementary Figs. 8a–c and 10). As expected from the general
expression pattern of the transgenic lines we employed, we
furthermore identified clusters representing immune cells in
cluster 5 (spi1b+, mpeg1.1+) and cluster 18 (mpx+, lyz+),
neuronal cells in cluster 7 (gfap+, npas1+) and cluster 15
(elav3+, elav4+), hypochord cells in cluster 23 (col8a1a+,
col2a1a+, fxyd1+, foxa1+, matn3b+) and epithelial cells in
cluster 16 and 17 (cdh1+, cldnb+, cdh17+, epcam+), likely
representing pronephric duct cells (Supplementary Figs. 8b, c
and 10).
Significantly, we found that 75% of the isolated cells grouped
into clusters that can be categorized as a general fibroblast
population, based on expression of classical fibroblast markers
such as pdgfra, col1a1a, lum, and dcn (Fig. 9c–f, Supplementary
Fig. 8b, c). Amongst those fibroblast clusters we noticed strong
enrichment for vegfc and ccbe1 transcripts within cluster 2, and to
Fig. 5 adamts3 expression via motoneurons or mesenchymal cells can rescue venous sprouting and PL formation in adamts3; adamts14 double
mutants. a Diagram depicting the heterochronic transplantation approach: Dextran-Alexa647 is injected into one-cell stage adamts14−/−; adamts3:Gal4FF;
UAS:GFP embryos (donor embryos). Cells are transferred from donor embryos to adamts3; adamts14 double mutants at 6 hpf (host embryo) and the effects
are assessed at 48 hpf. b, c In cases where transplanted cells contributed to adamts3-expressing motoneuron clusters (green arrowhead), venous ISVs
(white arrowhead), and PL cells (white arrow) formed in double mutants. c Transplanted cells labeled by Dextran-Alexa647. d When transplants gave rise
to adamts3+ cells at three locations, the HM, the ventral segment boundaries, and close to the DA and PCV, a local rescue of the formation of PL cells and
intersegmental veins in adamts3; adamts14 double mutant embryos was visible. e Zoom-in of the boxed region in (d) with adamts3-expressing cells at the
segment boundary highlighted by an arrow and transplanted cells at the HM marked by an arrowhead. f, g Transplantation of cells contributing to adamts3-
expressing cells at the ventral segment boundaries (blue arrow) and to cells located close to the DA (magenta arrow) and the PCV (white arrow) also
resulted in a locally restricted rescue of PL and vISV formation. g Zoom-in of the indicated region in f. h, i Cases, in which the transplants gave rise to
adamts3+ cells at the HM (arrowhead in i) and the region around the PCV (arrow in i), but not to the cells along the ventral segment boundaries showed a
rescue of PL cells and vISVs. j Overview about the results obtained from 23 rounds of cell transplantations. Each round contained 144 recipient embryos
obtained from an adamts3+/−; adamts14−/− incross of which a quarter was expected to be double mutant (in total 828). Embryos showing a rescue of PL
or vISV development were selected for imaging and genotyping. All embryos shown in (j) are adamts3; adamts14 double mutants. Scale bars: 50 µm. DA
dorsal aorta, hpf hours post fertilization, PCV posterior cardinal vein, PL parachordal lymphangioblast, vISV venous intersegmental vessel.
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some extent in clusters 1 and 4 (Fig. 9g, h). Given high expression
levels of genes related to cell proliferation (mki67, cdk1, top2a,
ccna2), we concluded that cluster 4 contains proliferating cells
(Supplementary Fig. 8b, c). Cluster 1 on the other hand seemed to
be related to cluster 2 and might represent a precursor state of the
more differentiated fibroblast population in cluster 2, as suggested
by velocity cell-differentiation prediction analysis (Supplementary
Fig. 9).
In order to narrow down which fibroblast cluster represents the
mesenchymal cell population expressing lymphangiogenic genes
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at the HM, we checked which transcripts would be specifically
highly expressed within cluster 2 when compared (a) with all
other clusters, (b) to all fibroblast clusters, or (c) to the closely
related progenitor cluster 1 (Supplementary Tables 1–3).
Amongst the most differentially expressed genes we noticed
engrailed 1a and engrailed 1b whose expression seems largely
confined to cluster 2 and to a lesser extent to some cells within
clusters 1 and 4 (Fig. 9i, j). Comparison between the vegfc, ccbe1
and en1a, en1b t-SNE plots demonstrated a high degree of
overlapping expression (Fig. 9g–j). We therefore performed
antibody staining at 48 hpf to check whether Engrailed expression
marks the cells of interest at the HM. Engrailed has been used as a
marker for muscle pioneer cells, which can be distinguished from
13 hpf onwards and are located at the midline36. These 2–6 cells
per somite represent a form of slow muscle fibers and are the first
muscle cells that differentiate36,37. We found that the Engrailed
antibody, which cross-reacts with zebrafish en1a, en1b, en2a, and
en2b38, showed restricted staining of nuclei in the HM region at
48 hpf. Importantly, all vegfc:Gal4FF;UAS:GFP positive cells at the
HM were also co-stained by Engrailed, but Engrailed also
highlighted other nuclei in the region (Supplementary Fig. 11a–c),
indicating that not only fibroblast populations express Engrailed
proteins at this stage of development in the midline area.
Antibody staining on pdgfra:mCit (Supplementary Fig. 11d–f) or
adamts3:Gal4FF;UAS:GFP embryos (Supplementary Fig. 11g–i)
revealed that pdgfra+ or adamts3+ cells at the HM, but not in
other embryonic regions, were co-stained by Engrailed, demon-
strating that the overlapping expression of en1a/en1b with vegfc
or pdgfra can be used as a specific landmark for the fibroblast
subpopulation at the HM.
After verifying that cluster 2 constitutes the fibroblast
subpopulation in question, we also checked expression of other
genes involved in lymphatic development in cells within this
cluster. The number of adamts3+ cells within cluster 2 was much
lower as compared with vegfc and ccbe1, indicating that the
protease would be secreted in a salt-and-pepper-like fashion by
only a fraction of HM fibroblasts at this stage (Fig. 9k). In
addition, several adamts3-expressing cells were found within the
neuronal clusters and within other fibroblast clusters, likely
reflecting the expression domains along segment boundaries and
around axial vessels. Finally, FAC-sorted cell populations
contained only very few cells with active adamts14 transcription,
that were mostly found in cluster 2 and the related cluster 1
(Fig. 9l), suggesting the fraction of pdgfra+ fibroblasts secreting
Adamts14 at the HM to be relatively small.
Two other important genes regulating the migration of
lymphatic precursor cells are cxcl12a and svep1, both of which
have been reported to be expressed by unknown cells located at
the HM39–41. In our scRNAseq data, cxcl12a-expressing cells
showed strong enrichment in cluster 2, very similar to vegfc and
ccbe1 (Fig. 9m). The svep1 gene has been reported to be expressed
at regions with venous and LEC migration activity, including the
HM. In line with the notion that only relatively few cells express
svep1 at the HM39, we found that only a fraction of the fibroblast
cells within cluster 2 actively express svep1 at 48 hpf (Fig. 9n).
These results demonstrate that also additional regulators of
lymphatic development are provided by fibroblast subpopulations
located at the HM, emphasizing their importance as local
signaling hubs within the embryonic trunk.
Our co-expression analysis using transgenic embryos (Fig. 7)
demonstrated that the expression of adamts3, ccbe1, and vegfc at
least partially overlaps at the HM, and that all cells expressing one
of these genes in this region would always be pdgfra-positive. In
order to assess whether a single pdgfra+ fibroblast at the HM
would likely express more than one of the genes involved in Vegfc
processing, we analyzed the co-expression of the respective
transcripts in cluster 2 cells in more detail (Fig.
9o–s, Supplementary Table 4). 80% (47/59) of the actively
vegfc-transcribing cells also contained ccbe1 transcripts, while
47% (47/99) of ccbe1-expressing cells also transcribed vegfc,
indicating that both genes have a high tendency to be co-
expressed (although more fibroblasts express ccbe1 (72%)
compared with vegfc (43%) at 48 hpf). The proportion of cells
within cluster 2 actively expressing adamts3 was 9% (13/137) and
for adamts14 3% (4/137). While we did not observe co-expression
of adamts3 and adamts14, we noticed that 85% (11/13) of
adamts3-expressing cells co-expressed ccbe1 and that the overlap
between adamts3 and vegfc was 38% (5/13). Interestingly, we also
identified fibroblast cells in cluster 2 expressing one of the two
protease genes together with vegfc and ccbe1 simultaneously (4/13
of adamts3+ or 1/4 of adamts14+ cells). Taken together, these
results indicate that although HM fibroblasts have a high
tendency to co-express several of the genes in question, the
proportion of cells expressing a particular gene at the HM at 48
hpf differs significantly, suggesting a certain heterogeneity
amongst this fibroblast population.
Guidance of PL cells requires Vegfc processing at the HM.
Since it has never been functionally addressed whether Vegfc
processing at the HM is required to recruit PLs to this region, we
assessed at which of the vegfc expression domains processing
needs to occur in order to allow for the formation of vISVs or
PLs, respectively. To this end, we locally expressed fully pro-
cessed, mature human VEGFC in mutants with disabled Vegfc
Fig. 6 adamts14-expressing floorplate and mesenchymal cells can rescue venous sprouting and PL formation in adamts3; adamts14 double mutants.
a Scheme outlining the transplantation assay: embryos homozygous mutant for adamts3 were injected with Dextran-Alexa647 to mark the donor cells. At
4 hpf, cells from the donor were transplanted into adamts3; adamts14 double mutant host embryos (6 hpf). Host embryos were subsequently analyzed for
rescue of venous sprouting and the location of the transplanted material at 48 hpf. b–d Transplantation of cells contributing to the floorplate (arrow)
resulted in the formation of intersegmental veins and venous sprouts reaching the HM region. c Dextran-Alexa647 labeled transplanted tissue. d Virtual
cross section showing the transplanted floorplate cells (white) in the rescued area. e–h In cases where the transplanted cells contributed to muscle but also
to individual cells at the HM (magenta arrow in f, g), at segment boundaries (blue arrow in f) and also to cells located directly adjacent to the DA and PCV
(blue arrow in h), PL formation and vISV formation was locally restored in adamts3; adamts14 double mutants. f Dextran-Alexa647 channel highlighting the
transplanted tissue. g, h Partial z-projections of the boxed regions in (e) indicating transplanted cells in white. i–k Transplants giving only rise to muscle
tissue did not rescue the venous sprouting defects in double mutants. j Dextran-Alexa647 labeled transplanted tissue. k Zoom-in of the boxed HM region
in j. l–n Cell transplantations giving rise to tissues including cells located at the HM (arrow in m) resulted in a rescue of PL and vISV formation in this area
at 48 hpf. n Virtual cross section indicating the position of the transplanted cell at the HM (arrow). o Graph summarizing the results from 13 rounds of cell
transplantations. Each round contained 144 recipient embryos derived from an adamts3+/−; adamts14−/− incross. From the expected 468 double mutant
recipients, embryos showing PL or vISV rescue were selected for imaging and genotyping. All embryos shown in (o) are adamts3; adamts14 double mutants.
Scale bars: 50 µm. DA dorsal aorta, HM horizontal myoseptum, hpf hours post fertilization, PCV posterior cardinal vein, PL parachordal lymphangioblast,
vISV venous intersegmental vessel.
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Fig. 7 Non-neuronal adamts3-expressing cells co-express vegfc and ccbe1. a Strategy for transcript analysis of adamts3-expressing cell populations by
RNA sequencing. adamts3:Gal4FF;UAS:GFP; NBT:dsRed-positive trunks were dissociated at 48 hpf and cells were FAC-sorted into (1) adamts3-expressing
neurons (GFP+ /dsRed+, yellow arrowhead), (2) adamts3+ non-neuronal cells (GFP+, green arrowheads) and (3) a negative control. Pooled cell
populations were analyzed by RNA sequencing. b Summary of RNA sequencing analysis. Values reflect fold-changes in transcript abundance for indicated
genes upon comparison of cell populations stated in the column headings. To identify significant gene expression differences, p values were determined by
Wald test and an FDR < 0.05 and FDR-adjusted p value < 0.1 cutoff was used (source data are provided as a Source Data file). c Lateral view of a vegfc:
Gal4FF; UAS:GFP; kdrl:mCherry transgenic embryo at 48 hpf. d Higher magnification showing vegfc expression in HM cells (white arrowhead), in the
hypochord (blue arrowhead), the DA (yellow arrowhead), in arteries (green arrowhead) and in neurons (magenta arrowhead). e Zoom-in of the boxed
region in (d) highlighting vegfc-expressing cells at the HM (arrowhead). f Virtual cross section focusing on the HM, showing juxtaposition between a PL
and vegfc-expressing cells (arrowhead). g Lateral view of a ccbe1:mCitrine; kdrl:mCherry transgenic embryo at 48 hpf showing ccbe1 expression in the
pronephros (blue arrow) and epiphysis (white arrow). h Higher magnification demonstrating ccbe1 expression at the HM (arrowhead). i Partial projection of
the marked region in (h) showing ccbe1-expressing cells at the HM (white arrowhead) and the segment boundary (yellow arrowhead). j Virtual cross
section indicating ccbe1+ cells at the HM (arrowhead). k, m, o Lateral views (partial z-projections) and l, n, p virtual cross sections of the HM region at
48 hpf. Arrowheads indicate cells with co-expression of the indicated transgenes. k, l adamts3 and vegfc are co-expressed by individual cells at the HM.
m, n Mesenchymal cells at the HM co-express adamts3 and ccbe1. o, p Overlapping expression of vegfc and ccbe1 in HM cells. Scale bars in a, d, h: 50 µm;
c, g: 100 µm; f, j, k, m, o 25 µm; l, n, p: 10 µm. DA dorsal aorta, HM horizontal myoseptum, hpf hours post fertilization, neg. negative cell population, sig.
significant.
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processing: injection of a UAS:ΔNΔC-VEGFC-P2A-RFP construct
into embryos double mutant for adamts3 and adamts14 and
harboring the vegfc:Gal4FF transgene (Fig. 10a) resulted in
mutant embryos that expressed fully mature VEGFC in a mosaic
fashion within the normal vegfc expression domains. Injected
embryos were subsequently analyzed for a rescue in vein and PL
formation, taking into account which cells provided processed
VEGFC (labeled by RFP expression).
Thus far, it had been assumed that vegfc is expressed only by
hypochord and DA cells at the time of secondary sprouting,
posing the question how Vegfc could instruct PLs to pass this area
and progress to the HM. When providing mature VEGFC at the
level of the DA by expression in either hypochord or DA cells, we
observed sprouting of venous endothelial cells in the immediate
proximity, resulting in the formation of a vISV close by
(Fig. 10b–e). In other cases, DA and especially hypochord
expression of ΔNΔC-VEGFC not only resulted in the formation
of a vein but also induced a local hyper-sprouting phenotype of
venous ECs, possibly due to higher expression levels of the
construct in these embryos. As a result, excessive venous
structures extended around the source of mature VEGFC protein
(Fig. 10f–i), indicating that the local levels of mature Vegfc need
to be tightly controlled to allow for normal vascular development.
A rescue of PL cells, in contrast, was only observed when
processed VEGFC was provided by fibroblasts at the HM region,
mostly in conjunction with expression within the DA (Fig. 10j–q).
These results indicate that controlled processing of endogenous











































Fig. 8 Co-expression of adamts3, ccbe1, and vegfc with pdgfra at the horizontal myoseptum. a–g Confocal images of pdgfra:mCitrine; kdrl:mCherry double
transgenic embryos at 48 hpf. a Lateral view giving an overview of the pdgfra-expression domains. b Higher magnification of the trunk region above the yolk
extension. c, d Virtual cross section of the trunk shown in b. d Zoom-in of the boxed area in (c) showing the HM region in detail. e–g Partial projections of
(b). e At the HM, pdgfra-expressing cells (in green) are surrounding the PL cells (in red). f pdgfra is expressed by cells located along the segment
boundaries (white arrow) as well as by individual cells located around the main axial blood vessels (yellow arrow). g At the level of the ISVs, individual
pdgfra+ cells locate in close proximity to the blood vessels. h–j, n–p, and t–v Lateral views and k–m, q–s, and w–y virtual cross sections of the HM region in
double transgenic embryos at 48 hpf. White arrows highlight cells with co-expression. h–m A subpopulation of pdgfra-expressing cells (green) is co-labeled
by the adamts3 reporter transgene (red) at the HM. n–s Cells at the HM co-express vegfc (red) and pdgfra (green). t–y All ccbe1-expressing cells at the HM
(red) show co-expression of pdgfra (green). Scale bar in a: 100 µm; b, c: 50 µm; e–j, n–p, t–v: 25 µm; k–m, q–s, w–y: 10 µm. DA dorsal aorta, HM horizontal
myoseptum, hpf hours post fertilization, ISV intersegmental vessel, PCV posterior cardinal vein, PL parachordal lymphangioblast.
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initial sprouting phase from the vein and the formation of vISVs.
In order to allow for formation of PLs, however, a source of
mature Vegfc at the HM region appears essential. We noticed that
in cases of PL rescue, lymphatic precursor cells would always end
up in direct proximity to the ΔNΔC-VEGFC-expressing fibro-
blasts, indicating that the sprouts indeed migrated toward the
source of mature VEGFC. The effects elicited by processed
VEGFC appeared locally restricted in all cases, suggesting that the
mature protein does not diffuse very far into neighboring
segments of the embryo.
Discussion
Here we assessed the expression and interplay of Adamts3 and
Adamts14 with Ccbe1 in N-terminal processing of secreted Pro-
Vegfc and hence the activation of the Vegfr3/Flt4 signaling
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Fig. 9 Single-cell RNA sequencing identifies fibroblast subpopulations expressing adamst3, adamts14, ccbe1, and vegfc. a Scheme of the partial
dissociation approach and the work flow. Note that embryonic trunks were not completely dissociated in order to obtain a higher proportion of cells from
more superficial tissues while reducing the amount of cells in the suspension originating from deeper tissues. b Pagoda2 clustering of the individual cell
transcriptomes gives rise to 24 clusters (labeled as C1-C24). c–n t-SNE plots indicating the transcript levels of the respective gene in each sequenced cell.
Expression of the general fibroblast markers pdgfra (c), col1a1a (d), lum (e), and dcn (f). Expression of ccbe1 (g) and vegfc (h) is largely restricted to cells
within cluster 2 as is the case for the expression of the genes en1a (i) and en1b (j). adamts3- (k) and adamts14-expressing cells (l) are distributed over
several clusters. m, n While cxcl12a-expressing cells are enriched in cluster 2, svep1-expressing cells can be found within several different clusters. t-SNE
plots highlighting cells co-expressing vegfc and ccbe1 (o), adamts3 and vegfc (p), or adamts3 and ccbe1 (q) as well as cells co-expressing adamts14 and vegfc
(r) or adamts14 and ccbe1 (s). Symbol shapes in the t-SNE plots indicate from which FACS run the cells had been obtained (circles and triangles originate
from sorts using vegfc:Gal4FF; UAS:GFP; kdrl:mCherry embryos, cells indicated by squares stem from the FAC-sorting of pdgfra:mCitrine embryos), color
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Fig. 10 Local Vegfc processing at the HM is required to guide endothelial cells to this region. a Schematic depiction of the mature human VEGFC
overexpression construct and the vegfc:Gal4FF transgenic line, which was used to drive mosaic expression of the construct upon transient injection. b–q vegfc:
Gal4FF positive embryos were injected with the overexpression construct at the one-cell stage and imaged at 48 hpf. All embryos shown are adamts3;
adamts14 double mutant, transgenic for flt4:mCitrine (green) and express UAS:ΔNΔC-VEGFC-P2A-RFP (red). b, c Expression of UAS:ΔNΔC-VEGFC-P2A-RFP in
hypochord cells (white arrow) rescues vein formation. d, e Local vISV rescue upon expression of mature VEGFC in DA cells (white arrowhead). f–i Venous
hyper-sprouting with ectopic venous structures formed in the vicinity of hypochord cells (f, g, arrows) or DA cells (h, i, arrowheads) with expression of the
ΔNΔC-VEGFC construct. j, k UAS:ΔNΔC-VEGFC-P2A-RFP positive fibroblasts recruit PL cells to the HM region. l, m Expression of mature VEGFC in
hypochord cells and in fibroblasts at the HM rescues vISV and PL formation in adamts3; adamts14 double mutant embryos. Note the close proximity of the PL
cell to the ΔNΔC-VEGFC producing fibroblasts. n, o Combined expression of mature VEGFC in DA cells and fibroblasts at the HM results in the formation of
vISV and PL cells close by. p, q Simultaneous expression of ΔNΔC-VEGFC in hypochord cells and in fibroblasts at the HM results in a local rescue of PL and
vISV formation but can additionally lead to a hyper-branching of venous structures at the level of the DA. c, e, g, i, k, m, o, q: Zoom-in image of the indicated
regions in b, d, f, h, j, l, n, p. Scale bars: 50 µm. DA dorsal aorta, HM horizontal myoseptum, hpf hours post fertilization, PL parachordal lymphangioblast, vISV
venous intersegmental vessel.
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In particular, using single cell sequencing and cell transplanta-
tions we resolved how the different cellular sources of the indi-
vidual players and their spatial positions determine the migratory
routes taken by the lymphatic precursor cells, which is relevant
for the correct patterning of the lymphatic system.
We surprisingly found that—in contrast to mice and men11–13
—zebrafish adamts3 knock-outs fail to display lymphatic defects.
Only the simultaneous loss of Adamts3 and Adamts14 activity
interferes with lymphatic development, resulting in an exception-
ally clean phenotype: adamts3;adamts14 double mutants fully
recapitulate the venous sprouting defects seen in ccbe1 and vegfc
mutants6,10,42, suggesting that in fish both Adamts3 and Adamts14
are able to activate Vegfc. One remaining wild-type copy of either
gene is sufficient to trigger lymphangiogenesis, demonstrating that
both proteases act redundantly. Zebrafish Adamts14 could also
activate human VEGFC in an in vivo activity assay (Fig. 2), which
prompted us to revisit the VEGFC cleavage capacity of human
ADAMTS14 in vitro. We found that human VEGFC is not only
proteolytically processed upon ADAMTS3 addition as described
previously8 but also in case recombinant ADAMTS14 protein is
added to the conditioned medium. The processing capacity of both
ADAMTS proteases is thus an evolutionary conserved feature.
Although ADAMTS3 seems to be the essential VEGFC-processing
protease during murine lymphatic sprouting11,12, future studies
will clarify a possible involvement of Adamts14 during other
aspects of lymphatic development.
adamts3 and adamts14 exhibit strong expression domains
within the spinal cord, but also possess partially overlapping
expression domains in fibroblast subpopulations located along
the migration route of LECs and the HM. Previous work has
indicated a correlation between the presence of specific moto-
neurons and the migration of lymphatic precursor cells towards
the HM, an area to which RoP motoneurons extend axonal
projections30. These results suggested a model in which moto-
neurons would be directly involved in guiding migrating PLs,
possibly by directed secretion of proteins from their axons, but
the exact nature of such a connection remained unclear. Here we
report that Adamts3 secreted by motoneurons directly impacts
the sprouting and migration of secondary sprouts. Cell trans-
plantations indeed showed that in absence of endogenous
Adamts3 or Adamts14, clusters of adamts3-expressing moto-
neurons are sufficient to rescue venous sprouting, the formation
of vISVs and even PL migration to the HM (Fig. 5). This estab-
lishes a direct connection between embryonic motoneurons and
the guidance of lymphatic precursor cells. For adamts14 we
identified persisting expression in the floorplate. In cases where
transplanted adamts14+/+ cells contributed to the floorplate in
double mutant embryos, a rescue of secondary sprouting could be
observed, identifying Adamts14 as a floorplate-derived protein
that influences embryonic lymphangiogenesis.
Besides these neuronal expression domains, we identified
additional sources for adamts3 and adamts14. A Tg(adamts3:
Gal4FF) reporter line highlights individual cells located close to
the PCV and DA as well as cells aligned along the segment
boundaries, reminiscent of a recently described population of
sclerotome-derived tendon fibroblasts called tenocytes43,44. Fur-
thermore, we found such cells at the HM, where they are posi-
tioned in direct contact to the incoming PL cells. Single cell
transcriptome analysis identified these cells as a population of
pdgfra-positive fibroblasts. This fibroblast subpopulation resident
at the HM and positive for en1a/en1b turned out to express not
only adamts3 and adamts14 in a salt-and-pepper-like fashion, but
also to provide other known key components of the Vegfc-
processing machinery such as Ccbe1 and Vegfc itself, which thus
far had been believed to be only provided by arterial cells of the
DA and ISVs, as well as by hypochord cells that are located
relatively far from the HM region to which lymphatic precursor
cells migrate. Employing transgenic reporters we confirm
expression domains for ccbe1 and vegfc within the pdgfra+
fibroblasts at the HM, indicating that this cell population provides
all players known to be required for the generation of fully active
Vegfc in the extracellular space. Thus, fully processed, mature
Vegfc protein is likely produced at the HM, guiding PLs to this
region.
In order to firmly establish at which location Vegfc maturation
needs to happen to allow for (1) normal sprouting and formation
of vISVs versus (2) the migration of lymphatic precursor cells to
the HM, we provided fully processed Vegfc in different anato-
mical compartments in a mosaic fashion. This analysis revealed
that processing at the level of the DA/hypochord can trigger
sprouting from the PCV and formation of intersegmental veins.
Ccbe1 and Adamts3 (and likely also Adamts14) are provided by
fibroblasts located close to the axial vessels, suggesting that for
this initial phase of migration, these fibroblasts provide the
molecular components for Vegfc to mature and to allow forma-
tion of vISVs. In an independent step, future PL cells that will go
on to populate the HM region seem to depend on a local source
of mature Vegfc at the HM, as we only observed normal PL
formation in embryos that contained fibroblasts expressing the
ΔNΔC-VEGFC construct at the HM. Given the expression of all
required factors in pdgfra+ fibroblasts in this area, the secretion
of these factors by the same or neighboring fibroblasts at the HM
region would lead to the local production of mature Vegfc, in
turn attracting and guiding the lymphatic precursor cells on their
way from the DA/hypochord area to the superficial HM. Fur-
thermore, our characterization of the en1a/en1b-positive HM
fibroblast population indicates that these cells also provide
additional proteins that have been shown to be essential for
lymphatic development and which do not have an established
direct connection to the regulation of Vegfc processing (cxcl12a
and svep1), emphasizing the importance of this cell population as
local signaling hubs producing various key regulators of lym-
phatic migration in the trunk.
The here reported expression of lymphangiogenic factors by
fibroblast subpopulations seems to be an evolutionary conserved
feature: The publicly available mouse limb muscle dataset of the
Tabula Muris single cell transcriptomics database45, contains an
unannotated cell population showing expression of Adamts3,
Ccbe1, and Vegfc. Similar to the zebrafish situation, the three
genes are only expressed by subpopulations of this cell group.
Remarkably, we found that more than 30 orthologs out of the 50
most differentially regulated genes within zebrafish fibroblast
cluster 2 (Supplementary Fig. 10) are also expressed in this
mouse cell population (including fibroblast-enriched genes such
as Dcn, Col1a1, Col1a2, or Mmp235). This strongly suggests that
a related fibroblast subpopulation to the one we characterize
here also exists in muscle tissue of adult mice, and that this cell
population can also serve as a source for Vegfc signaling com-
ponents. Our dataset hence compiles an array of genes and
identifies a specific subpopulation of fibroblasts that is not only
relevant for zebrafish lymphangiogenesis, but might also be used
in other physiological contexts and in other species,
including human.
Methods
Zebrafish husbandry and strains. Zebrafish (Danio rerio) strains were main-
tained according to FELASA recommendations46. Animal experiments have been
performed according to guidelines of the animal ethics committees at the Uni-
versity of Münster, Germany. Embryonic developmental stages were determined
according to reference47.The following published transgenic lines have been
employed in this study: Tg(flt4:mCitrine)hu713548, Tg(flt1enh:tdTomato)hu533349, Tg
(shh:vegfc-IRES-mTurquoise)hu1093310, Tg(kdrl:HRASmCherry)s9166 referred to as
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kdrl:mCherry, Tg(mnx1:GFP)ml250, Tg(NBT:dsRed)zf14851, Tg(isl1:Gal4FF)hu663552,
Tg(UAS:GFP)nkuasgfp1a, Tg(UAS:RFP)nkuasrfp1a 53.
Transgenesis. The Tg(adamts3:Gal4FF)mu400, Tg(pdgfra:mCitrine, cmlc2:mTur-
quoise)mu401, Tg(vegfc:Gal4FF)mu402, Tg(vegfc:mCitrine)mu403, Tg(ccbe1:mCitrine)
hu6741, Tg(ccbe1:Gal4FF)hu8876 transgenic reporter lines were generated from BAC
DNAs (listed in Supplementary Table 5) following standard BAC recombineering
procedures49. Briefly, using BAC recombineering in Escherichia coli the long
terminal repeats of the Medaka Tol2 transposon were inserted into the BAC clones
(in case of the pdgfra reporter line containing a cmcl2:mTurquoise expression
cassette as a selection marker for transgenesis). In a second step, the respective
reporter cassette (mCitrine or Gal4FF) was inserted replacing the first translated
ATG of the targeted gene. 150–300 pg of the modified BAC DNA and 25 pg Tol2
mRNA were injected into one-cell embryos.
Genome editing. TALEN constructs for the generation of adamts3hu10891,
adamts3hu11981, adamts14hu11304, and adamts2hu11300 mutant alleles were assem-
bled following the Golden Gate method and employing the GoldyTALEN modified
scaffold54,55. The TALEN binding sites in adamts3 exon 3 were: TAL1, 5′-GCCA
TGGTGGAATGGCACGAT-3′; TAL2, 5′- AGCTGGAAATGCGACTGATA-3′.
The TALEN binding sites in adamts3 exon 5 were: TAL1, 5′-TGATGATTCTG
TCGTCC-3′; TAL2, 5′-AGCATGTGCAGAACT-3′. The TALEN binding sites in
adamts14 exon 3 were: 5′-CTGGGAACAAACATCAACAT-3′; TAL2, 5′-GATCC
TGGTGGGATATCGAC-3′. The TALEN binding sites in adamts2 exon 6 were:
TAL1, 5′-TTTTCTCACCAGACAAGA; TAL2, 5′-CATGCAGGGTAATTCATT
TT-3′. One-cell embryos were injected with 50–200 pg of the respective mixed
TAL1/TAL2 mRNAs. All selected TALEN binding sites flanked a central restriction
enzyme site that was used for subsequent screening and efficacy testing.
For the generation of the adamts2_likehu11325 allele CRISPR-mediated genome
editing was performed56. The sgRNA target site in adamts2_like (XM_009303
692.3; LOC101883894) exon 2 was 5′-GGGCAATCCTTCTCAGAGTC-3′ and
spanned a genomic HinfI restriction enzyme site which was used for subsequent
screening and efficacy testing. One-cell stage embryos were injected with 150 pg of
zebrafish codon-optimized nls-zCas9-nls mRNA and 25 pg adamts2 sgRNA.
Genotyping. adamts3 and adamts14 were genotyped by KASPar. adamts2 and
adamts2_like were genotyped by PCR and restriction enzyme digestion. shh:zfvegfc
was genotyped by PCR. The corresponding primers and restriction enzymes are
listed in Supplementary Tables 6, 7.
In situ hybridization (ISH). Antisense RNA probes for adamts3 and adamts14
were generated from cDNA by PCR amplification of a template fragment using
primers with a T3 promoter overhang (Supplementary Table 8) followed by
in vitro transcription with T3 RNA polymerase using digoxigenin (DIG)-labeled
UTP (2 h, at 37 °C). The vegfc probe was generated from a plasmid template57
using T7 RNA polymerase. ISH was carried out following standard procedures58
with the following changes: After fixation (4% paraformaldehyde in PBS, over-
night at 4 °C) and storage in 100% methanol, the 26/36/48 hpf embryos were
treated with proteinase K for 10 min at room temperature at a concentration of
10 µg/mL. After re-fixation (4% paraformaldehyde, 20 min), washing with PBST
and pre-hybridization at 65 °C, embryos were incubated in hybridization buffer
containing DIG-labeled antisense probes at 65 °C for at least 12 h. For the
detection of vegfc, 100 ng of the column-purified probe were added to the
hybridization buffer. For adamts3 and adamts14 transcript detection, 100 ng of
each of the respective probes 1–3 (Supplementary Table 8) were combined and
used for the hybridization. All subsequent washing steps, the incubation with anti-
DIG primary antibody (sheep anti-Digoxigenin-AP Fab Fragments, 1:2000, Roche,
cat-no. 11093274910, Lot: 16646822) and the alkaline-phosphatase-conjugated
secondary antibody as well as the staining reaction using NBT/BCIP substrates
was performed according to the published protocol. Embryos were imaged on a
Nikon Eclipse Ni microscope.
RNAscope. RNAscope probes for adamts3, adamts14, ccbe1, and vegfc (Supple-
mentary Table 9) were designed and synthesized by ACD, a bio techne brand. The
RNAscope transcript detection was performed on embryos that were fixed in 4%
paraformaldehyde at RT for 20 min using the RNAscope Fluorescent Multiplex
Reagent Kit (ACD) and following standard procedures26: Fixed embryos were
washed three times for 5 min in 1 ml PBT (0.1% Tween), followed by a series of
dehydration steps: 25, 50, 75, and 100% methanol for 5 min each. After overnight
incubation in 100% methanol at −20 °C the solution was completely removed and
the embryos were air-dried at room temperature for 30 min. Two drops of Pretreat
3 were added and the embryos were incubated at room temperature for 20 min.
The individual probes were simultaneously heated up to 40 °C in the water bath for
10 min and were brought back to room temperature before the respective C1, C2,
and C3 probes were mixed in a 50:1:1 ratio with a final volume of 50 μl per tube.
After Pretreat 3 incubation, embryos were washed three times with PBT at room
temperature followed by an incubation in 50 μl of mixed target probes at 40 °C
overnight. After three washes with 0.2X SSCT for 15 min each at room
temperature, embryos were re-fixed in 4% PFA for 10 min at room temperature
and washed three times 15 min with 0.2x SSCT at room temperature. Embryos
were subsequently incubated in two drops of Amp1 solution from the kit for
30 min at 40 °C followed by three 15 min washing steps in 1 ml 0.2X SSCT at room
temperature. Analogous incubation and washing steps were performed for Amp2
(15 min incubation), Amp3 (30 min incubation), and Amp4 (15 min incubation)
solution. After the final wash with 0.2X SSCT at room temperature, embryos were
stained in two drops of DAPI solution from the kit at 4 °C overnight, washed with
PBT and imaged on a Leica SP8 confocal microscope.
Immunohistochemistry. Antibody staining was performed according to a pre-
viously published protocol59. In brief, embryos were fixed in 4% PFA overnight at
4 °C, washed three times 5 min with 100% methanol on ice and incubated in
methanol with 3% H2O2 for 60 min on ice. Afterwards, embryos were washed three
times 5 min with 100% methanol on ice and then kept in 100% methanol at −20 °C
for at least 2 days before use. Embryos were washed with PBT (0.1% Tween 20)
three times for 10 min and incubated in PBT with 30% sucrose (w/v) overnight at
4 °C. After three more washes with PBT for 10 min each, embryos were incubated
in 150 mM Tris-HCl (pH 9.0) for 5 min, followed by an incubation at 70 °C for
15 min. The embryos were washed two times with PBT 10min and with distilled
water twice for 5 min each. Afterwards, embryos were transferred to ice-cold
acetone and incubated at −20 °C for 40 min. Then, embryos were washed two
times with PBT 5min before they were treated with 10 µg/ml Proteinase K in PBT
for 10 min at room temperature and re-fixed with 4% PFA at room temperature for
20 min. After three more washing steps in PBT for 5 min each embryos were rinsed
with cold TBST (0.1% Triton X-100), followed by a blocking step with 1% BSA and
10% goat serum in TBST overnight at 4 °C. Primary antibodies in blocking buffer
were applied to the embryos, which were then incubated overnight at 4 °C on a
shaker. Embryos were washed five times with TBST for 30 min each, once with
Maleic buffer (150 mM Maleic acid; 100 mM NaCl; 0.001% Tween 20 pH 7.4) for
30 min at room temperature, followed by an incubation in 2% blocking reagent
(Roche) in Maleic buffer at RT for 2–3 h. The secondary antibody in 2% blocking
reagent was added and the embryos were incubated overnight at 4 °C. On the
following day, embryos were washed with Maleic buffer five times 30 min each and
rinsed with PBS. After the washing steps, PBS was removed and 100–150 μl tyr-
amide signal amplification reagent was added. The embryos were incubated at
room temperature for 3 h in dark before they were washed with TBST several times
during the next 1–2 days at room temperature on a shaker before imaging and
analysis.
The following antibodies were used at the indicated dilutions: mouse anti-
engrailed 4D9 primary (1:4; Developmental Studies Hybridoma Bank, University of
Iowa, Antibody Registry ID: AB_528224) with Peroxidase AffiniPure Goat Anti-
Mouse IgG, light chain specific secondary (1:100; Jackson Immuno Research, cat-
no. 715-035-150) followed by Alexa568-tyramide signal amplification reagent (TSA
kit, PerkinElmer, cat-no. 2305851); chicken anti-GFP primary (1:400, Abcam, cat-
no. ab13970) with Alexa488-conjugated goat anti-chicken secondary (1:200,
Invitrogen, cat-no. A11039).
Cell transplantation assay. Heterochronic cell transplantations were performed
by using 4 hpf donor and 6 hpf host embryos. Approximately 20 cells were taken
from the donor’s animal pole and transferred close to the host’s lateral marginal
zone (for fibroblast cells), or slightly above for neuronal cells. Donor embryos were
injected with dextran-Alexa647 to identify the transplanted cells in host embryos.
In addition, adamts3 wild-type donor embryos positive for Tg(adamts3:gal4;UAS:
GFP) were used to highlight the adamts3-expressing cells within the transplant.
Protein purification and VEGFC-processing assay. For purification of
ADAMTS3 and ADAMTS14 recombinant proteins, a previously published pro-
tocol was adopted60. Stably transfected cells were grown in DMEM supplemented
with 10% fetal calf serum and hygromycin. Upon confluence, the growth medium
was replaced by serum free DMEM containing soybean trypsin inhibitor (40 µg/
ml), heparin (5 µg/ml), and ZnCl2 (80 µM). After 48 h the medium was collected,
concentrated, and subsequently loaded on a 25 ml Concanavalin A-Sepharose
column that was pre-equilibrated in buffer A (50 mM Tris pH 7.5; 1 M NaCl; 2 mM
CaCl2). After a washing step with buffer A, protein elution was performed using
buffer A supplemented with 500 mM α-methyl-D-mannoside. The fractions con-
taining recombinant enzymes were then dialyzed against buffer B (50 mM Tris pH
7.5; 0.2 M Na Cl2) before they were loaded on a 5 ml heparin-Sepharose column,
washed with buffer B and finally eluted in buffer A. Note that the precise con-
centration of active ADAMTS proteins cannot be determined accurately since each
enzyme preparation consists of several co-purifying polypeptides with different
molecular weights and different activities. Quantifications of purified proteins were
made after SDS-PAGE and staining with SYPRO Orange using known con-
centrations of BSA as reference. Only the product around 105 kDa was taken into
account, as this polypeptide corresponds to the expected molecular weight of the
fully mature ADAMTS form. Values of 8 and 12 ng/µl were obtained for
ADAMTS3 and ADAMTS14, respectively.
HEK293 cells expressing human pro-VEGFC were cultured for 48 h in DMEM
containing 0.1% FBS, 0.2 mM AEBSF (serine protease inhibitor), and 50 µM
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Decanoyl-RVKR-CMK (furin inhibitor). For the processing assay, 20 µl of
conditioned medium were supplemented with NaCl (0.3 M final concentration)
and 8 µl of either ADAMTS3, ADAMTS14 or control buffer in the absence or
presence of 25 mM EDTA (used as an inhibitor of metalloproteinases) in a total
volume of 40 µl. After an 18 h incubation at 37 °C, samples were denatured in
reducing conditions (1x Laemmli sample buffer containing 200 mM DTT).
Western blotting analysis was performed using a polyclonal goat anti-human
VEGFC primary antibody (1:200, R&D, AF752). Note that the VEGFC antibody
does not react with the 29kDa C-terminal domain of VEGFC and shows relatively
low affinity for the fully processed mature 21 kDa form.
FACS. Approximately 100 trunks of the respective transgenic 48 hpf embryos were
incubated in 600 μl autoclaved PBS at 30 °C for 15 min. After a centrifugation at
600 rpm for 4 min the supernatant was discarded and the trunk was subsequently
partially dissociated in 1 ml 0.5% trypsin-EDTA (Gibco) supplemented with 10 U
DNaseI (Promega) for 30 min at 30 °C. During this incubation step, the solution
was pipetted up and down three times every 10 min. After addition of 300 μl PBS
(to dilute the trypsin) the mixture was centrifuged at 900 rpm at room temperature
for 5 min. The pellet was resuspended in 300 μl PBS and filtered through a Falcon
40 µm cell strainer to exclude undissociated tissue fragments using a gentle cen-
trifuge step at 600 rpm for 30 s. Under these conditions the trunks were not
completely dissociated thereby enriching for cells that were located closer to the
surface while decreasing the proportion of cells in the solution that originated from
more central regions within the trunk. Dissociated cells were sorted directly into
lysis buffer using a FACSAria IIIu cell sorter (BD Biosciences) with FACSDiva 8.0.1
(https://www.bdbiosciences.com/) and FlowJo 10.6.1 (https://www.flowjo.com/)
software. For pooled cell populations, RNA extraction and sequencing were carried
out by the Core Facility Genomics Münster.
Smart-seq2 library preparation and sequencing. Single-cell cDNA libraries were
prepared as described before61. In brief, cDNA was transcribed from mRNA using
oligo(dT) primer and SuperScript II reverse transcriptase (ThermoFischer). Second
strand cDNA was synthetized using a template switching oligo. The double
stranded cDNA was then amplified by PCR for 24 cycles. The quality and quantity
of purified cDNA was controlled using a 2100 BioAnalyzer with a DNA High
Sensitivity Chip (Agilent Biotechnologies) and Qubit (ThermoFischer). Upon
passing quality control (QC), the cDNA was fragmented using Tn5 transposase,
and each single well was uniquely indexed using the Illumina Nextera XT index kits
(Set A–D). The indexed cDNA libraries from one 384-well plate were pooled into
one sample and sequenced on one lane of a HiSeq3000 sequencer (Illumina), using
dual indexing and single 50 base-pair reads.
Sequence analysis and data processing. After sequencing of pooled cDNA
libraries as described above, the sequences were de-multiplexed into single-cell
fastq files applying standard parameters of the Illumina pipeline (bcl2fastq) using
Nextera index adapters. The individual fastq files were mapped to the zebrafish
reference genome GRCz11, using TopHat2 with Bowtie2 option62,63 where adapter
sequences were removed using trim galore before read mapping. Doublets were
removed using the samtools software. The generated BAM files containing the
results of the alignment were sorted according to the mapping position, and raw
read counts for each gene were calculated using featureCounts function from the
Subread software package64. As technical control, 92 artificial RNA sequences
(ERCCs) were added to the lysis buffer and in the mapping pipeline.
After mapping and gene counting, the data for the individual cells was
combined into an expression matrix dataset showing raw counts per gene of each
individual cell as input data. The annotation of the ENSEMBL identifiers was done
using the org.Dr.eg.db (version 3.7.0) package in R-software, retaining the ERCC
counts to be used as technical controls in the dataset.
The resulting expression data were analyzed using the software packages
velocyto (http://velocyto.org)65, SingleCellExperiment66 and pathway and gene set
overdispersion analysis (pagoda2) (https://github.com/hms-dbmi/pagoda2)67,
applying standard QC, normalization and analysis procedures. In brief, the
expression matrix was structured and organized using the SingleCellExperiment R-
software package. Low quality cells were filtered in a stepwise manner. First, cells
with low library sized (<50,000 counts), and number of expressed genes (≤1500)
were removed from the dataset. If necessary, also cells with high percentage of
reads mapped to ERCCs (>10 %) were removed. Cells with an unusual high
number of expressed genes (>10,000) were removed as potential doublets. Non- or
low-expressed genes were removed, due to the criteria: gene expression in at least
three cells with a cumulative counts value of 300, considering the complete dataset.
After QC, the cells were normalized to 500,000 counts total library size. For
clustering, the QC- and gene expression-filtered raw counts expression matrix was
loaded into the pagoda2 R-software package. PCA analysis was performed in
pagoda2 using the attributes (nPca= 50, n.odgenes= 3000), followed by nearest
neighbor clustering. For visualization t-stochastic neighbor embedding (t-SNE) was
used as embedded functions in the pagoda2 or SingleCellExperiment R-software
package. For cell-differentiation prediction (RNA-velocity), the velocyto software
package was applied using standard parameters. For the co-expression analysis, a
threshold of ≥20 counts per cell was used for adamts3, adamts14, ccbe1, and vegfc
to qualify as an active expressing cell.
Microscopy. Confocal imaging was performed on living embryos embedded in
0.8% low melting point agarose (Invitrogen) with 0.0168% tricaine (Sigma A-5040)
on a Leica SP8 microscope employing Leica LAS X 3.5.6.21594 software (https://
www.leica-microsystems.com/). Images were processed using Adobe Photoshop
CC 2017 (https://www.adobe.com/products/photoshop.html) and Fiji [(Fiji Is Just)
ImageJ2.0.0-rc-43/1.52 u](http://fiji.sc/Fiji). Stitching of composite pictures was
performed using Adobe Illustrator CC 2015 (https://www.adobe.com/products/
illustrator.html). 3D-reconstructions of z-stacks were done with Bitplane Imaris
8.2.1 (https://imaris.oxinst.com/). For light microscopy, a Nikon Eclipse Ni
microscope with NIS-Elements 4.40.00 software (https://www.microscope.
healthcare.nikon.com/) was employed.
Statistics and reproducibility. The following section indicates how often
experiments have been repeated independently with similar results. The phenotypic
analysis of adamts3 and adamts14 single and double mutants (Fig. 1c–e, g–i, l–q,
Supplementary Fig. 1d, e) was performed at least five times, quantifications of PLs
and vISVs (Fig. 1k) were done at least two times and the analysis of all other single
or double mutant combinations (Fig. 1j and Supplementary Fig. 1b, c) was done at
least two times. The in vivo zebrafish Vegfc-processing assays (Fig. 2b–i) were done
at least three times each while the in vitro processing assay (Fig. 2j) was performed
five times. The adamts3 ISH (Fig. 3a–c) was done three times and the adamts3:
Gal4FF transgene analysis was performed five times (Fig. 3d, i–m) and two times in
conjunction with the motoneuronal marker mnx1:GFP (Fig. 3e, f). adamts14
expression analysis by ISH and RNAscope (Fig. 4) was performed at least three
times each. Cell transplantation assays for adamts3 (Fig. 5) and adamts14 (Fig. 6)
were conducted at least 13 times each. Transgene co-expression (Fig. 7c–p) was
assessed three independent times and the expression pattern of the pdgfra reporter
alone and in combination with other transgenes (Fig. 8) was analyzed at least three
times. Rescue experiments with a mature VEGFC construct (Fig. 10) were per-
formed six times. The axonal pattern of motoneurons in adamts3;adamts14 double
mutants (Supplementary Fig. 2) was analyzed at least two times for the indicated
time points. Expression analysis for vegfc by ISH (Supplementary Fig. 4) was
performed once and the expression analysis for vegfc, ccbe1, adamts14 and pdgfra
by RNAscope (Supplementary Figs. 5–7) was done at least two times. The
Engrailed antibody stainings have been performed twice for all combinations
(Supplementary Fig. 11a–i) and the ISH against nuak1b (Supplementary Fig. 11k, l)
and itgbl1 (Supplementary Fig. 11n, o) were done two times.
All images shown in the figures are representative examples of the respective
phenotypes and expression patterns. Statistical analysis of PL and vISV
quantifications was performed with GraphPad Prism 8 (https://www.graphpad.
com/scientific-software/prism/).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that the data supporting the findings of this study are available
within the paper and its supplementary information files. The raw single-cell RNA
sequencing data of this study have been deposited in the NCBI’s Gene Expression
Omnibus database under the accession code: GSE146923.
Source data underlying Figs. 1k, 2j, and 7b are provided as a Source Data file.
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